| Pathophysiology of atopic dermatitis: Clinical implications |
20 |
| Systemic inflammation mediates the detrimental effects of obesity on asthma control |
16 |
| Role of innate lymphoid cells in allergic diseases |
14 |
| Diagnosis, pathogenesis, and treatment of chronic spontaneous urticaria |
11 |
| The burden of atopic dermatitis |
10 |
| Clinical updates in aspirin-exacerbated respiratory disease |
9 |
| A cross-sectional, population-based survey of US adults with symptoms of chronic rhinosinusitis |
9 |
| Peanut allergy: Burden of illness |
9 |
| Efficacy of probiotic supplementary therapy for asthma, allergic rhinitis, and wheeze: a meta-analysis of randomized controlled trials |
9 |
| Interleukin 33 and interleukin 4 regulate interleukin 31 gene expression and secretion from human laboratory of allergic diseases 2 mast cells stimulated by substance P and/or immunoglobulin E |
8 |
| Anaphylaxis risk factors for hospitalization and intensive care: A comparison between adults and children in an upstate New York emergency department |
7 |
| Update on peanut allergy: Prevention and immunotherapy |
7 |
| Long-term omalizumab outcomes in chronic idiopathic urticaria: a real-world study |
7 |
| Seasonal variability of exacerbations of severe, uncontrolled eosinophilic asthma and clinical benefits of benralizumab |
7 |
| Epidemiology of childhood asthma in mainland China (1988-2014): A meta-analysis |
7 |
| Correlation between vitamin D serum levels and passive smoking exposure in children with asthma |
6 |
| Evaluating children with suspected allergic reactions to vaccines for infectious diseases |
6 |
| Health care burden and treatment patterns in commercially insured children with chronic idiopathic/spontaneous urticaria: A real-world study in the United States |
6 |
| Improved diagnostic clarity in shrimp allergic non-dust-mite sensitized patients |
6 |
| Association of alopecia areata with atopic dermatitis and chronic spontaneous urticaria |
6 |
| Impact of patient satisfaction with his or her inhaler on adherence and asthma control |
5 |
| Real-world use of omalizumab in patients with chronic idiopathic/spontaneous urticaria in the United States |
5 |
| Hereditary angioedema from the patient's perspective: A follow-up patient survey |
5 |
| Hereditary and acquired angioedema |
5 |
| Atopic dermatitis |
5 |
| Factors predicting anaphylaxis in children with tree nut allergies |
4 |
| Effect of omalizumab on outcomes in patients with aspirin-exacerbated respiratory disease |
4 |
| Risk factors for diagnostic delay in Chinese patients with hereditary angioedema |
4 |
| Meta-analysis of randomized controlled trials for the efficacy and safety of anti-interleukin-13 therapy with lebrikizumab in patients with uncontrolled asthma |
4 |
| Cost impact of monitoring exhaled nitric oxide in asthma management |
4 |
| The dilemma of allergy to food additives |
4 |
| Efficacy and safety of omalizumab in pediatric patients with high immunoglobulin E levels: A case series |
4 |
| Association between urticaria and nematode infections |
4 |
| The effect of preoperative penicillin allergy testing on penoperative non-beta-lactam antibiotic use: A systematic review and meta-analysis |
3 |
| Assessment of atopic dermatitis as a risk factor for chronic spontaneous urticaria in a pediatric population |
3 |
| New and evolving therapies for hereditary angioedema |
3 |
| Asthma control, lung function, symptoms, and corticosteroid sparing after omalizumab initiation in patients with allergic asthma |
3 |
| Pediatric cutaneous mastocytosis and c-KIT mutation screening |
3 |
| Early life obesity increases the risk for asthma in San Francisco born Latina girls |
3 |
| Immunobiologic treatments for severe asthma, atopic dermatitis, and chronic urticaria |
3 |
| Pearls and pitfalls in the diagnosis of hereditary angioedema |
3 |
| Factors related to omalizumab resistance in chronic spontaneous urticaria |
3 |
| Olopatadine-mometasone combination nasal spray: Evaluation of efficacy and safety in patients with seasonal allergic rhinitis |
3 |
| Evaluating satisfaction of patients with hereditary angioedema with their past and present treatments: Implications for future therapies |
3 |
| Characterizing patients with asthma who received Global Initiative for Asthma steps 4-5 therapy and managed in a specialty care setting |
3 |
| Chronic rhinosinusitis with nasal polyps in the elderly: Assessing current evidence |
3 |
| Efficacy of recombinant human C1 esterase inhibitor across anatomic locations in acute hereditary angioedema attacks |
3 |
| Subcutaneous C1-esterase inhibitor to prevent hereditary angioedema attacks: Safety findings from the COMPACT trial |
3 |
| Early risk factors for cow's milk allergy in children in the first year of life |
3 |
| Long-term safety and efficacy of olopatadine-mometasone combination nasal spray in patients with perennial allergic rhinitis |
3 |
